Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer

Study Overview
=================
Brief Summary
-----------------
This study observes conversations between non-small cell lung cancer patients and their doctors to support the development of a decision aid that can be used to inform discussions about treatment options for after surgery. Patients who have undergone surgery for their non-small cell lung cancer may have the option of completing additional treatment. Patients contemplating this additional treatment have been shown to be most satisfied with their choice if they perceive an effort by their doctor to share decision making. Shared decision making tools can help doctors guide conversations, offer tailored recommendations, and support deliberation on whether or not to pursue treatment. This study develops a shared decision making tool for patients with surgically removed non-small cell lung cancer contemplating additional treatment.

Detailed Description
-----------------
PRIMARY OBJECTIVE: I. To develop, in close collaboration with stakeholders, an evidence-based decision aid to inform discussions regarding options for adjuvant treatment in patients with resected non-small cell lung cancer (NSCL) (NSCL adjuvant choice). OUTLINE: Patient and clinician discussions are observed to support refinement of a decision aid. Clinicians may use a prototype of the decision aid in discussions with their patients and may complete a questionnaire.

Official Title
-----------------
The Development of a Shared Decision-Making Encounter Tool for Decisions of Adjuvant Treatment in Patients With Resected Non-Small Cell Lung Cancer

Conditions
-----------------
Lung Non-Small Cell Carcinoma

Intervention / Treatment
-----------------
* Procedure: Discussion
* Other: Questionnaire Administration


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: PATIENTS: Adults >= 18 years with biopsy proven resected non-small cell lung cancer (NSCLC) Appointments to discuss adjuvant treatment of resected NSCLC CLINICIANS: Clinicians who meet with patients to discuss adjuvant treatment of resected NSCLC PAG MEMBERS: Adults >= 18 years Member of the Knowledge and Evaluation Research (KER) Unit Patient Advisory Group (PAG) Exclusion Criteria: PATIENTS Major barriers to providing informed consent (i.e., dementia, severe hearing or visual impairment)

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Observational (discussion)<br>Patient and clinician discussions are observed to support refinement of a decision aid. Clinicians may use a prototype of the decision aid in discussions with their patients and may complete a questionnaire. | Procedure: Discussion<br>* Attend discussion<br>Other: Questionnaire Administration<br>* Complete questionnaire<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Development of decision aid |  | Up to study completion, up to 2 years |